iA Global Asset Management »

Biomarin Pharmaceutical shares owned by iA Global Asset Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by iA Global Asset Management from 13F filings

Historical chart of iA Global Asset Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by iA Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by iA Global Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 15M 1.03
2023-09-30 $15M 15M 1.00

More positions owned by iA Global Asset Management

Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
UnitedHealth (UNH)
Apple (AAPL)
S&p Global (SPGI)
MasterCard Incorporated (MA)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Costco Wholesale Corporation (COST)
Danaher Corporation (DHR)
iShares iBoxx $ High Yid Corp Bond (HYG)
Vanguard Short Term Corporate Bond ETF (VCSH)

View all positions for iA Global Asset Management

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Lazard Asset Management
Wellesley Investment Advisors
iA Global Asset Management
Victory Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management
Bank of America Corporation
Jpmorgan Chase & Co
Wellington Management Company
Amundi
New York State Common Retirement Fund
Bnp Paribas Investment Partners
SSI Investment Management
La Banque Postale Asset Management SA

View all funds holding Biomarin Pharmaceutical